Clinical Trial: A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821750) titled 'A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults' on Feb. 06.

Brief Summary: The purpose of this clinical trial is to learn if the study medicine (called PF-07314470) is safe and how it gets in and out of the body in healthy people.

Study Start Date: Feb. 11

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: BIOLOGICAL: PF-07314470

subcutaneous injection

BIOLOGICAL: Placebo for PF-07314470

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Pfizer

Published by HT Digital Content Services with permission from Hea...